ArticleInternational journal of molecular sciences2022

Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA.

Nico Dreymann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.